Randall Mrsny - Applied Molecular CoFounder Director

Insider

Randall Mrsny is CoFounder Director of Applied Molecular Transport
Age 68
Phone650 392 0420
Webhttps://www.appliedmt.com

Applied Molecular Management Efficiency

The company has return on total asset (ROA) of (0.5125) % which means that it has lost $0.5125 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5805) %, meaning that it created substantial loss on money invested by shareholders. Applied Molecular's management efficiency ratios could be used to measure how well Applied Molecular manages its routine affairs as well as how well it operates its assets and liabilities.
Applied Molecular Transport currently holds 36.12 M in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Applied Molecular has a current ratio of 6.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Applied Molecular's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Josh EizenAN2 Therapeutics
N/A
Alexander MSFennec Pharmaceuticals
N/A
Dan WilliamsInhibikase Therapeutics
N/A
Paul MDAN2 Therapeutics
54
Victoria RacBio Path Holdings
N/A
MD MBARezolute
N/A
Mark GowlandFennec Pharmaceuticals
N/A
Brian MDRezolute
50
James CollinsSenti Biosciences
58
Surendra SinghInhibikase Therapeutics
N/A
Erick MDAcrivon Therapeutics, Common
67
Deborah KnobelmanSenti Biosciences
50
Donna DeaAerovate Therapeutics
N/A
Anne MoonTempest Therapeutics
N/A
Eric DevroeAcrivon Therapeutics, Common
46
Philip LeeSenti Biosciences
42
Rasmus HolmJorgensenAcrivon Therapeutics, Common
53
Eric EasomAN2 Therapeutics
57
Justin TrojanowskiTempest Therapeutics
36
Peter MBABio Path Holdings
75
Benjamin DakeAerovate Therapeutics
49
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. Applied Molecular operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 125 people. Applied Molecular Transport (AMTI) is traded on NASDAQ Exchange in USA and employs 13 people.

Management Performance

Applied Molecular Leadership Team

Elected by the shareholders, the Applied Molecular's board of directors comprises two types of representatives: Applied Molecular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Applied. The board's role is to monitor Applied Molecular's management team and ensure that shareholders' interests are well served. Applied Molecular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Applied Molecular's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Chang, Head Communications
Earl Douglas, Exec Counsel
Bittoo MD, Chief Officer
Graham Cooper, Ex Chairman
Shawn Cross, Pres COO
Tahir Mahmood, CEO CoFounder
Andy Whitney, VP Science
MBA MBA, Chief Officer
Randall Mrsny, CoFounder Director
Brandon Hants, Chief Officer

Applied Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Applied Molecular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Applied Stock

If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like